CMOPF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cosmo Pharmaceuticals NV

Watchlist Manager

Watchlist

Price: 78.79 USD 3.33% Market Closed

Market Cap: $1.3B

	Cosmo Pharmaceuticals NV OTC:CMOPF	IE
F	First Hydrogen Corp OTC:FHYDF	CA
	Tilaknagar Industries Ltd BSE:507205	IN

Profitability Summary

Cosmo Pharmaceuticals NV's profitability score is 42/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

49%

Strong 3Y Average Gross Margin

66%

Declining Gross Margin

60% > 49%

Negative Operating Margin

-3%

Sustainable 3Y Average Operating Margin

25%

Declining Operating Margin

26% > -3%

Negative Net Margin

-3%

Sustainable 3Y Average Net Margin

18%

Declining Net Margin

10% > -3%

Negative Free Cash Flow Margin

-17%

Strong 3Y Average Free Cash Flow Margin

29%

Declining Free Cash Flow Margin

View All

Hide

Collapse

42 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.